A Phase 2, randomized, double blind, placebo-controlled study of zanubrutinib treatment in patients hospitalized for COVID-19 infection and pulmonary distress

 IMAGE   09/2020

For more information about this publication, please submit a medical information request.

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service